FDA Approves AstraZeneca No-Needle At-Home ‘Live’ Virus Flu Vaccine with 90% Shed Rate
FluMist manufacturer insert confirms vaccinated can infect unvaccinated.
In September, the U.S. Food and Drug Administration (FDA) approved AstraZeneca’s FluMist for self or caregiver administration for the 2024-2025 influenza season. Alarmingly, the FDA package insert indicates that the vaccinated can shed (or transmit) the vaccine virus onto the unvaccinated, potentially infecting them.
https://jonfleetwood.substack.com/p/fda-approves-astrazeneca-no-needle?